SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC
February 22, 2026
 · 
6 min read
Press Releases
Virion Therapeutics Reports Broad and Sustained Anti-HBV Immunity Following a Single VRON-0200 Dose in the Majority of Chronically HBV-Infected Patients From its Phase 1b Study at CROI 2026
February 22, 2026
 · 
4 min read
Press Releases
Dyne Therapeutics Announces Upcoming Presentations Across Neuromuscular Pipeline at 2026 MDA Clinical & Scientific Conference
February 22, 2026
 · 
7 min read
Press Releases
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
February 22, 2026
 · 
24 min read
Press Releases
Gyder Surgical announces first commercial surgical cases in the United States performed by Dr. Paul M. Lombardi, M.D., at the Tri-County Orthopedics’ Joint Replacement Institute outpatient center
February 22, 2026
 · 
2 min read
Press Releases
TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years
February 22, 2026
 · 
26 min read
Press Releases
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
February 22, 2026
 · 
10 min read
Press Releases
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
February 22, 2026
 · 
5 min read
Press Releases
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
February 22, 2026
 · 
5 min read
Press Releases
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 20, 2026
February 22, 2026
 · 
2 min read
Press Releases
AltaPointe Health Study Finds Low-Dose Ketamine Helps Fentanyl Users Start Buprenorphine Without Severe Withdrawal
February 22, 2026
 · 
3 min read
Press Releases
Science Corp. and Neurosoft Bioelectronics Announce Novel BCI Ecosystem Partnership
February 22, 2026
 · 
4 min read
Press Releases
Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation
February 22, 2026
 · 
11 min read
Press Releases
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
February 22, 2026
 · 
4 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - February 20, 2026
February 22, 2026
 · 
3 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 20, 2026
February 22, 2026
 · 
1 min read
Press Releases
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
February 22, 2026
 · 
1 min read
Press Releases
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
February 22, 2026
 · 
17 min read
Press Releases
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 22, 2026
 · 
1 min read
Press Releases
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 20, 2026
February 22, 2026
 · 
2 min read
Press Releases
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 20, 2026
February 22, 2026
 · 
2 min read
Press Releases
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 20, 2026
February 22, 2026
 · 
3 min read
Press Releases
FDA Clears FluoGuide’s IND for FG001 in High-Grade Glioma; U.S. Clinical Trial Remains on Track
February 22, 2026
 · 
3 min read
Press Releases
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
February 22, 2026
 · 
8 min read
Press Releases
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences - February 5, 2026
February 5, 2026
 · 
2 min read
Press Releases
AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
February 5, 2026
 · 
6 min read
Press Releases
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
February 5, 2026
 · 
5 min read
Press Releases
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 5, 2026
 · 
4 min read
Press Releases
VectorY Therapeutics Appoints Kevin Pojasek, Ph.D., to Board of Directors
Experienced biotech executive brings more than 20 years of leadership experience in company creation, strategy, and drug development
February 5, 2026
 · 
1 min read
Press Releases
Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026
February 5, 2026
 · 
1 min read
Press Releases
Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
February 5, 2026
 · 
4 min read
Press Releases
Empyrean Medical Systems Signs Exclusive Distribution Agreement for Greater China
February 5, 2026
 · 
4 min read
Press Releases
Aspivix Achieves New Milestone: Study Results Peer-Reviewed and Published in the International Journal of Gynecology & Obstetrics
February 5, 2026
 · 
4 min read
Press Releases
Calico Appoints Joseph R. Arron, M.D., Ph.D., as Head of Human Biology and Genetics
February 5, 2026
 · 
3 min read
Load More